Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/81478
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSverdlov, A.en
dc.contributor.authorChan, W.en
dc.contributor.authorProcter, N.en
dc.contributor.authorChirkov, Y.en
dc.contributor.authorNgo, D.en
dc.contributor.authorHorowitz, J.en
dc.date.issued2013en
dc.identifier.citationInternational Journal of Cardiology, 2013; 168(5):4624-4630en
dc.identifier.issn0167-5273en
dc.identifier.issn1874-1754en
dc.identifier.urihttp://hdl.handle.net/2440/81478-
dc.description.abstract<h4>Background</h4>Impaired tissue responsiveness to nitric oxide (NO) occurs in many cardiovascular diseases as well as with advanced age and is a correlate of poor outcomes. This phenomenon results from oxidative stress, with NO "scavenging" and dysfunction of soluble guanylate cyclase (sGC). Thioredoxin-interacting protein (TXNIP) is a major intracellular regulator of inflammatory activation and redox stress, but its interactions with NO/sGC are poorly understood. We have now evaluated the relationship between platelet TXNIP expression and function of the NO/sGC axis in subjects of varying age and during therapy with ramipril.<h4>Methods & results</h4>Young (n=42) and aging (n=49) subjects underwent evaluation of platelet TXNIP content. Aging subjects additionally had measurements of platelet NO responsiveness and routine biochemistry. Platelet TXNIP content was greater (376±33 units) in the aging compared to younger subjects (289±13 units; p<0.05). In the aging subjects there was a significant negative correlation (r=-0.50, p<0.001) between platelet TXNIP content and NO responsiveness. In a separate cohort of 15 subjects two week treatment with ramipril, which reversed platelet NO resistance and potentiated sGC activity, also decreased platelet TXNIP content by 40% (p=0.011).<h4>Conclusions</h4>Platelet TXNIP content increases with aging, varies inversely with responsiveness to NO, and diminishes rapidly following treatment with ramipril. These data suggest that TXNIP-induced oxidative stress may be a critical modulator of tissue resistance to NO, a fundamental basis for cardiovascular disease. Analogously suppression of TXNIP expression can potentially be utilized as an index of restoration of cardiovascular homeostasis.en
dc.description.statementofresponsibilityAaron L. Sverdlov, Wai P.A. Chan, Nathan E.K. Procter, Yuliy Y. Chirkov, Doan T.M. Ngo, John D. Horowitzen
dc.language.isoenen
dc.publisherElsevier Sci Ireland Ltden
dc.rightsCopyright © 2013 Published by Elsevier Ireland Ltd.en
dc.subjectNitric oxide; Thioredoxin-interacting protein; ACE inhibitors; Aging; Plateletsen
dc.titleReciprocal regulation of NO signaling and TXNIP expression in humans: Impact of aging and ramipril therapyen
dc.typeJournal articleen
dc.identifier.rmid0020132552en
dc.identifier.doi10.1016/j.ijcard.2013.07.159en
dc.identifier.pubid17560-
pubs.library.collectionMedicine publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidSverdlov, A. [0000-0003-2539-8038]en
dc.identifier.orcidHorowitz, J. [0000-0001-6883-0703]en
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.